Asosiy kontentga oʻtish
Maqola

Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma

Kimberly NoonanJohns Hopkins University School of Medicine, 1650 Orleans Street, CRB1 Room 453, Baltimore, MD 21231, USACarol Ann HuffJohns Hopkins MedicineJanice M. DavisJohns Hopkins University School of Medicine, 1650 Orleans Street, CRB1 Room 453, Baltimore, MD 21231, USAM. Victor LemasJohns Hopkins University School of Medicine, 1650 Orleans Street, CRB1 Room 453, Baltimore, MD 21231, USASusan FiorinoJohns Hopkins MedicineJeffrey BitzanJohns Hopkins MedicineAnna FergusonJohns Hopkins MedicineAmy EmerlingJohns Hopkins MedicineLeo LuznikJohns Hopkins MedicineWilliam MatsuiJohns Hopkins University School of Medicine, 1650 Orleans Street, CRB1 Room 453, Baltimore, MD 21231, USAJonathan D. PowellJohns Hopkins University School of Medicine, 1650 Orleans Street, CRB1 Room 453, Baltimore, MD 21231, USAEphraim J. FuchsJohns Hopkins MedicineGary L. RosnerJohns Hopkins MedicineCaroline EpsteinJohns Hopkins University School of Medicine, 1650 Orleans Street, CRB1 Room 453, Baltimore, MD 21231, USALakshmi RudrarajuJohns Hopkins University School of Medicine, 1650 Orleans Street, CRB1 Room 453, Baltimore, MD 21231, USARichard F. AmbinderJohns Hopkins MedicineRichard J. JonesJohns Hopkins University School of Medicine, 1650 Orleans Street, CRB1 Room 453, Baltimore, MD 21231, USADrew M. PardollJohns Hopkins University School of Medicine, 1650 Orleans Street, CRB1 Room 453, Baltimore, MD 21231, USAIvan BorrelloJohns Hopkins University School of Medicine, 1650 Orleans Street, CRB1 Room 453, Baltimore, MD 21231, USA
2015en
ABI

Annotatsiya

Marrow-infiltrating lymphocytes (MILs) may be used as adoptive cell therapy for multiple myeloma.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba